Kidney Failure, Chronic: all 2,121 studies

Page 5 of 22. Open to participants first (264), then studies with results posted, then the rest; newest registration first within each.

• Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous FistulaCompletedNCT02414204Not applicableResults posted
• Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5CompletedNCT02392208Phase 4Results posted
• TARGTEPO Treatment for Anemia in End Stage Renal Disease (ESRD) Patients Undergoing Peritoneal Dialysis (PD)TerminatedNCT02378662Phase 2Results posted
• Percutaneous Less Invasive AV Fistula for Vascular Access in ESRDCompletedNCT02363972Not applicableResults posted
• A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}CompletedNCT02358343Phase 3Results posted
• Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for HemodialysisCompletedNCT02335099Phase 1/2Results posted
• Acid-Base Composition With Use of hemoDialysatesCompletedNCT02334267Not applicableResults posted
• A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or HemodiafiltrationCompletedNCT02331680Phase 2Results posted
• Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)CompletedNCT02314403Phase 1Results posted
• Clinical Study of Asahi ViE Dialyzer in CanadaCompletedNCT02292212Not applicableResults posted
• Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD TrialCompletedNCT02285920Phase 2Results posted
• Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2CompletedNCT02278562Phase 2Results posted
• Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable DialysisCompletedNCT02278341Phase 3Results posted
• Reveal LINQ™ Evaluation of FluidTerminatedNCT02275923Not applicableResults posted
• Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of EvolocumabCompletedNCT02275156Phase 1Results posted
• 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic HemodialysisCompletedNCT02260193Phase 2Results posted
• Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal DialysisCompletedNCT02243306Phase 1Results posted
• Bupropion for Depression in ESRD Patients on HemodialysisTerminatedNCT02238977Phase 4Results posted
• Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRDCompletedNCT02228408Phase 4Results posted
• Bone Mass and Strength After Kidney TransplantationCompletedNCT02224144Phase 2Results posted
• Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney DiseaseCompletedNCT02207088Phase 3Results posted
• Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis PatientsTerminatedNCT02165761Not applicableResults posted
• Effects of Exercise and Improved Nitric Oxide Bioavailability on Arteriovenous Fistula MaturationTerminatedNCT02164318Not applicableResults posted
• Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis PatientsCompletedNCT02159859Phase 2Results posted
• Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal DiseaseCompletedNCT02158052Not applicableResults posted
• A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With HemodialysisCompletedNCT02144285Phase 1Results posted
• C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRICompletedNCT02134314Phase 1/2Results posted
• TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD)CompletedNCT02117427Phase 1/2Results posted
• A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized PatientsCompletedNCT02086682Results posted
• Coronary Artery Disease Screening in Kidney Transplant CandidatesCompletedNCT02082483Not applicableResults posted
• Specialized Community Disease Management to Reduce Substance Use and Hospital ReadmissionsCompletedNCT02059005Not applicableResults posted
• Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving DialysisCompletedNCT02054572Phase 1Results posted
• Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy SubjectsCompletedNCT02022748Phase 1Results posted
• A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on HemodialysisCompletedNCT01999582Phase 2Results posted
• ISCHEMIA-Chronic Kidney Disease TrialCompletedNCT01985360Phase 4Results posted
• Comparing Everolimus and Sirolimus in Renal Transplant RecipientsCompletedNCT01976390Not applicableResults posted
• Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal DiseaseCompletedNCT01974817Phase 4Results posted
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)CompletedNCT01950819Phase 4Results posted
• Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal DiseaseCompletedNCT01949532Phase 1Results posted
• Improving Communication About Serious IllnessCompletedNCT01933789Not applicableResults posted
• A Study of LY2409021 in Participants With Different Levels of Kidney FunctionCompletedNCT01929109Phase 1Results posted
• Sodium Chloride and Protein-Bound Toxin Removal in HemodiafiltrationCompletedNCT01923961Not applicableResults posted
• A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers.CompletedNCT01920854Phase 1Results posted
• Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal DialysisCompletedNCT01895322Phase 2Results posted
• Use Of Fragmin In HemodialysisCompletedNCT01879618Phase 3Results posted
• A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or HemodiafiltrationCompletedNCT01876381Phase 2Results posted
• Renal Allograft Tolerance Through Mixed ChimerismCompletedNCT01780454Phase 1/2Results posted
• Monitoring in Dialysis -- a Prospective, Multi-center, Single-arm, Non-randomized, Observational Study in Patients Who Are Undergoing Hemodialysis.CompletedNCT01779856Not applicableResults posted
• Treatment Modification to Reduce Symptom Burden in HemodialysisCompletedNCT01775800Not applicableResults posted
• Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on HemodialysisCompletedNCT01764854Phase 2Results posted
• Improved Selection of Elderly (> 65 Years) for Kidney TransplantationActive, not recruitingNCT01760733Results posted
• Pruritus in Patients With Chronic Kidney DiseaseCompletedNCT01727180Results posted
• Pharmacokinetics And Dialysability Of CP-690,550 In Subjects With End-Stage Renal DiseaseCompletedNCT01710020Phase 1Results posted
• Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving HemodialysisTerminatedNCT01660243Phase 2Results posted
• Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive RegimensCompletedNCT01653847Not applicableResults posted
• Hyperglycemia in Renal TransplantationCompletedNCT01643382Not applicableResults posted
• The Everolimus-Transplant Exit Strategy Trial (E-TEST)TerminatedNCT01636466Phase 3Results posted
• Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney DiseaseCompletedNCT01630889Phase 2Results posted
• A Phase 3, Long-Term Safety Study of Subcutaneous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME -Anemia Management With EpoetinCompletedNCT01628120Phase 3Results posted
• A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01628107Phase 3Results posted
• Propaten Randomized Investigation on Cost-benefit and EfficacyTerminatedNCT01601873Not applicableResults posted
• A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney TransplantationCompletedNCT01594424Phase 1/2Results posted
• A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on DialysisCompletedNCT01554982Phase 3Results posted
• Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept StudyTerminatedNCT01537315Phase 2Results posted
• A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring HemodialysisCompletedNCT01537042Phase 3Results posted
• Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic HemodialysisCompletedNCT01503021Phase 3Results posted
• A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01473420Phase 3Results posted
• A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With EpoetinCompletedNCT01473407Phase 3Results posted
• Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)FistulaeCompletedNCT01471041Phase 2/3Results posted
• Safety and Dialysability of Dotarem® in Dialysed PatientsCompletedNCT01449266Phase 1Results posted
• Effect of Short Term Aliskiren Treatment in Kidney Transplant PatientsTerminatedNCT01437943Phase 4Results posted
• Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis PatientsCompletedNCT01435174Phase 4Results posted
• Blood Pressure in Dialysis PatientsCompletedNCT01421771Not applicableResults posted
• Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis PatientsCompletedNCT01395823Phase 4Results posted
• A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or HemodialysisCompletedNCT01382212Phase 3Results posted
• Exercise Intolerance in Renal FailureCompletedNCT01356966Phase 2Results posted
• HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving HemodialysisCompletedNCT01343251Results posted
• Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on HemodialysisCompletedNCT01340586Phase 1Results posted
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)CompletedNCT01322347Phase 3Results posted
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis PatientsCompletedNCT01320202Phase 3Results posted
• Effect of Adipokines in Hemodialysis PatientsCompletedNCT01301027Not applicableResults posted
• Prevention of Peritonitis in Peritoneal DialysisCompletedNCT01293799Not applicableResults posted
• Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney TransplantationCompletedNCT01289548Not applicableResults posted
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis PatientsCompletedNCT01286012Phase 2Results posted
• Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid GlandsCompletedNCT01273597Results posted
• A Representational Intervention to Promote Preparation for End-of-life Decision MakingCompletedNCT01259011Not applicableResults posted
• Journeys to Wellness: A Transplant Candidate StudyCompletedNCT01254214Phase 3Results posted
• Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal DiseaseCompletedNCT01247090Phase 2Results posted
• Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During HaemodialysisCompletedNCT01241539Phase 1Results posted
• Safety and Dose Finding Study of Xigris in Hemodialysis PatientsCompletedNCT01227187Phase 2Results posted
• Impact of Vitamin D Therapies on Chronic Kidney DiseaseCompletedNCT01222234Not applicableResults posted
• Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) PatientsCompletedNCT01219959Phase 3Results posted
• Nasal Tea Tree Oil for the Prevention of Infections in PD PatientsCompletedNCT01214395Phase 2Results posted
• A Study in Participants With End-Stage Renal DiseaseCompletedNCT01200290Phase 2Results posted
• Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney TransplantationCompletedNCT01178216Phase 1/2Results posted
• Impact of Vitamin D Repletion in Hemodialysis PatientsCompletedNCT01175798Not applicableResults posted
• Evaluation of the GORE® ACUSEAL Vascular Graft for Hemodialysis AccessCompletedNCT01173718Phase 2/3Results posted
• Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance HemodialysisCompletedNCT01147666Phase 2Results posted
• A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.CompletedNCT01146574Phase 2Results posted
• Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical PracticeTerminatedNCT01134315Results posted

← Kidney Failure, Chronic overview